AERI

Aerie Pharmaceuticals, Inc.
AERI

Overview Fund Activity
Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

167 hedge funds and large institutions have $1.39B invested in Aerie Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 60 increasing their positions, 47 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
–
Holders Change %
0%
% of All Funds
3.3%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.16%
New
36
Increased
60
Reduced
47
Closed
36
Calls
$17.2M
Puts
$6.21M
Net Calls
+$11M
Net Calls Change
+$1.8M

Top Buyers

1
Franklin Resources
Franklin Resources
California
$27.6M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
$26.6M
3
Bank of America
Bank of America
North Carolina
$28M
4
Citigroup
Citigroup
New York
$22.3M
5
PHS
PFM Health Sciences
California
$58.3M

Top Sellers

1
DM
Deerfield Management
New York
$42.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
$0
3
WRF
Waddell & Reed Financial
Kansas
$21.8M
4
Goldman Sachs
Goldman Sachs
New York
$2.21M
5
SAM
Sectoral Asset Management
Quebec, Canada
$18.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
FGAM
201
Financial Gravity Asset Management
Texas
– -$2K -95 Closed
GWS
202
Glassman Wealth Services
Virginia
– -$1K -41 Closed
5 6 7 8
9